iShares U.S. Pharmaceuticals -$0.16 -0.23% Friday 19:59
1D 1W 1M 3M 1Y 5Y
1.43 % Dividend Yield
This list is based on the watchlists of people on Stock Events who follow IHE. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Invesco Pharmaceuticals
PJP
Mkt Cap 277.72M
PowerShares Dynamic Pharmaceuticals ETF, directly competes by investing in U.S. pharmaceutical companies. SPDR Pharmaceuticals
XPH
Mkt Cap 180.51M
SPDR S&P Pharmaceuticals ETF, tracks a similar S&P Pharmaceuticals Select Industry Index, making it a direct competitor. Fidelity MSCI Health Care Index
FHLC
Mkt Cap 3.05B
Fidelity MSCI Health Care Index ETF, includes a significant allocation to pharmaceuticals, competing in the healthcare sector. Vanguard Health Care
VHT
Mkt Cap 18.14B
Vanguard Health Care ETF, has a broad exposure to the healthcare sector, including pharmaceuticals, making it a competitor. iShares U.S. Healthcare
IYH
Mkt Cap 3.41B
iShares U.S. Healthcare ETF, competes by investing in U.S. healthcare stocks, including pharmaceuticals. Health Care Select Sector SPDR
XLV
Mkt Cap 40.3B
Health Care Select Sector SPDR Fund, competes as it includes major pharmaceutical companies in its holdings. VanEck Biotech
BBH
Mkt Cap 448.52M
VanEck Vectors Biotech ETF, while focused on biotech, it competes due to overlap in pharmaceuticals and healthcare. Invesco Biotechnology & Genome
PBE
Mkt Cap 262.64M
Invesco Dynamic Biotechnology & Genome ETF, competes indirectly through its focus on biotech, which includes companies involved in pharmaceuticals. Miscellaneous
Investment Trusts/Mutual Funds
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Show more...